A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with ...

Marker Therapeutics (NASDAQ:MRKR – Get Free Report) is expected to announce its earnings results before the market opens on ...

The reconstructed 3D cell tissue is subjected to a PET scan. Innovative system enables efficient evaluation of future cancer ...

An AI-based computer model makes aging visible at the cellular level for the first time. Researchers have applied it to ...

will present at the H.C. Wainwright 3 rd Annual Cell Therapy Virtual Conference. This virtual investor event will be held on February 25, 2025. Dr. Vera will present an overview of Marker’s technology ...

Researchers have developed pig retinal organoids to understand how stem cell-derived photoreceptor cells work as a ...

Dr. Yang Jian, leader of the team that published the Nature article unveiling a new method known simply as "gsMap" Photo: ...

Our immune system works to fight infections immediately, but also maintain long-term immunity. Two waves of protection help neutralize and eliminate diseas | Immunology ...

Fintel reports that on March 5, 2025, Canaccord Genuity initiated coverage of Marker Therapeutics (NasdaqCM:MRKR) with a Buy recommendation. Analyst Price Forecast Suggests 750.00% Upside As of March ...

In a nutshell Scientists discovered that an enzyme called SSAT1 turns helpful immune cells into harmful ones in psoriasis, ...

An FFG-funded consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien together with company partner DOC Medikus GmbH has developed an innovative ...

Cancer is the rapid proliferation of malignant cells that permeate tissue and cause dysregulation of the body’s daily functions. Many cancers can be | Immunology ...